IL-17 Inhibitors in Psoriasis: From Clinical Data to RWE

Introduction

In this lecture, Prof. Diamant Thaçi will go through key IL-17 Inhibitors Clinical Data including Metanalysis showing differences among biologics highlighting some of the RWE available and some of his own experience as well in the treatment of Psoriasis.

Objectives

1. How moderate-to-severe plaque psoriasis affects patients’ quality of life
2. Real-world evidence to better understand the long-term effectiveness and safety of biologics

This Course For :

Physician ( Allergy & Immunology , Dermatology , Rheumatology )
Resident / Fellow ( Allergy & Immunology , Dermatology , Rheumatology )

Speaker

Sponsored by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 30 Mar 2022    To    07 Apr 2022
  • 08:30 PM  To  11:59 PM
  • Certificate Available
  • Online Recorded
  • 148
  Add to Calendar 03/30/2022 08:30 PM 04/07/2022 11:59 PM Asia/ Riyadh IL-17 Inhibitors in Psoriasis: From Clinical Data to RWE IL-17 Inhibitors in Psoriasis: From Clinical Data to RWE https://medicalacademy.org/portal/event/view/1712
IL-17 Inhibitors in Psoriasis: From Clinical Data to RWE